Envista Holdings Corp(NVST) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 30 at 4:13 PM ET (Korea 10/1 05:13)
Full metrics table
| Index | - | P/E | 40.77 | EPS (ttm) | 0.58 | Insider Own | 2.33% | Shs Outstand | 160.6M | Perf Week | -1.47% |
| Market Cap | 3.77B | Forward P/E | 14.08 | EPS next Y | 8.79% | Insider Trans | -0.21% | Shs Float | 156.9M | Perf Month | -13.52% |
| Enterprise Value | 4.23B | PEG | 0.93 | EPS next Q | 0.36 | Inst Own | 117.89% | Short Float | 6.51% | Perf Quarter | -13.62% |
| Income | 0.10B | P/S | 1.32 | EPS this Y | 28.8% | Inst Trans | 6.15% | Short Ratio | 3.59 | Perf Half Y | -7.49% |
| Sales | 2.86B | P/B | 1.23 | EPS next 5Y | 15.18% | ROA | 1.69% | Short Interest | 10.21M | Perf YTD | 8.11% |
| Book/sh | 19.16 | P/C | 3.35 | EPS past 3/5Y | -40.82% 6.49% | ROE | 3.06% | 52W High | -22.85% ($30.42) | Perf Year | 15.22% |
| Cash/sh | 7.01 | P/FCF | 15.19 | Sales past 3/5Y | 1.91% 7.11% | ROIC | 2.05% | 52W Low | 25.04% ($18.77) | Perf 3Y | -15.82% |
| Dividend Est. | - | EV/EBITDA | 10.11 | EPS Y/Y TTM | 85.76% | Gross Margin | 55.86% | Volatility(W/M) | 2.37% 3.12% | Perf 5Y | -43.87% |
| Dividend TTM | - | EV/Sales | 1.48 | Sales Y/Y TTM | 11.89% | Oper. Margin | 10.61% | ATR (14) | 0.74 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 2.07 | EPS Q/Q | 110.55% | Profit Margin | 3.33% | RSI (14) | 33.43 | Recom | 2.07 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.43 | Sales Q/Q | 7.1% | SMA20 | -6.01% ($24.97) | Beta | 0.89 | Target Price | $30 |
| Payout | - | Debt/Eq | 0.52 | Earnings | 2026/8/5 | SMA50 | -11.41% ($26.49) | Rel Volume | 0.7 | Prev Close | $23.33 |
| Employees | 12000 | LT Debt/Eq | 0.5 | EPS/Sales Surpr. | 22.28% 2.01% | SMA200 | -8.5% ($25.65) | Avg Volume(3M) | 2.85M | Price | $23.47 |
| IPO | 2019/9/18 | Option/Short | Yes/Yes | Trades | 15158 | Volume | 2,005,043 | Change | 0.6% |
A global dental healthcare company that manufactures and supplies dental products. It offers implants and orthodontic devices, as well as dental consumables and equipment, maintaining an extensive product portfolio aimed at dental professionals and patients. It is a specialized company in the dental healthcare sector.
Over the past 1 year, roughly in the middle
23% below its 1-year high.
Traded less than usual That is 70% of its average volume.
NVST earns at a steady pace
Of every $100 in sales, $10.61 is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +28.8% this year.
Tap to view numbers
The price is about the industry average
For a company expected to earn $100 next year, you would pay $1,408. Peers typically go for $1,870. Compared with its own 4-year average, it is 58% pricier now.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -43.9%. The S&P 500 did +78% over the same period.
Tap to view numbers
No dividend
It reinvests profits in the business instead of paying dividends.
Ownership looks stable
Institutions hold 117.9%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #20 of 51 in the industry
Based on market cap of $4B.
ICUI#19 ICU Medical Inc $4B PER 135.6 NVST#20 Envista Holdings Corp $4B PER 40.8 
PLSE#21 Pulse Biosciences Inc $4B PER - 
WRBY#22 Warby Parker Inc $3B PER 457.7 
ATRC#23 Atricure Inc $3B PER 259.6 
FAQ
What kind of company is NVST?
NVST belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is the market cap of NVST?
The market cap of NVST is approximately $3.8B, ranking 1,564 within its sector.
What is the P/E ratio of NVST?
NVST has a P/E ratio of approximately 40.8x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for NVST?
NVST has recorded a 52-week high of $30.42 and a low of $18.77.
